Sort By:

Norovirus – 2026

This Phase III clinical trial is designed to evaluate the safety, tolerability, and effectiveness of an investigational Norovirus vaccine candidate. The study seeks to determine if the vaccine can effectively prevent norovirus acute gastroenteritis (AGE) in a specific population group.

You can contact our office at 501-623-9930 or fill out the short "Do You Qualify" Questionnaire to see if you qualify for this study.

View Trial Details
Ages 60+
Compensation* TBD for study related time and travel
Study Topics Vaccine to prevent norovirus acute gastroenteritis

*Compensation for time and travel may be available to those who qualify.

Flu Vaccine – Fall 2026

This study is an influenza vaccine compared with a licensed inactivated influenza vaccine for ages 65 and older.
Seasonal flu viruses are estimated by the World Health Organization to cause 3-5 million cases of severe illness and up to 650,000 deaths a year. Seasonal flu vaccine recommendations are designed to cover the strains of in flu determined to be the most prominent for the current flu season. The WHO (World Health Organization) recommends 3 strains to be used since one B-strain has not been prominent since 2020.
Improved vaccine immune response in adults age 50 and older is needed as the current licensed seasonal flu vaccines rarely exceed 60% effectiveness. Flu vaccines based on mRNA technology could provide several benefits in older adults compared with current vaccines including: the ability to respond to changes in the flu strain more quickly, avoid mutations that may be acquired in egg-based vaccine production, and exhibit a stronger immune response and protection.

You can contact our office at 501-623-9930 or fill out the short "Do You Qualify" Questionnaire to see if you qualify for this study.

View Trial Details
Ages 65+
Compensation* TBD for study related time and travel
Study Topics Prevention of Influenza

*Compensation for time and travel may be available to those who qualify.

Vaccine Studies

Baptist Health Center for Clinical Research is looking for people who may be interested in participating in research studies evaluating Investigational Vaccines against several common viral illnesses. Compensation for time and travel is usually $400-$1500+.

There may be several different studies available, including studies looking at the prevention of Flu, RSV, pneumococcus and COVID. This may also include some non vaccine investigational drugs that protect against some of these viral illnesses.

For more information, please answer the "Do you qualify" question and then fill out the brief contact form or you can call 501-623-9930.

No obligation. No health insurance required. No cost to participate.

Thank you.

View Trial Details
Ages 18+
Compensation* TBD for study related time and travel

*Compensation for time and travel may be available to those who qualify.